Margrit Schwarz

Margrit Schwarz is an accomplished professional with extensive experience in the life sciences and investment sectors. Current positions include serving as a Scientific Advisory Board Member at EvlaBio AG and as a Member of the Board Director Pool European Investment Fund with the European Investment Bank. Margrit also contributes as an Advisory Board Member at IMMUNETHEP and as an Entrepreneur in Residence at BiOrigin, Novo Seeds. Additional roles include being an Expert for Innosuisse and the European Innovation Council and SMEs Executive Agency, along with holding a Board Member position at the KERN LIPID CONFERENCE. As CoFounder and CEO of BlackWay Biosciences AG, Margrit leads innovative initiatives. Educational achievements include dual MBAs from Columbia Business School and the University of California, Berkeley, along with a Ph.D. in Biochemistry from the University of Cologne and a Diploma in Chemistry from the University of Münster.